Upper Motor Neuron-Predominant Motor Neuron Disease: A Novel Immunotherapy-Responsive Association of GAD65 Autoimmunity (P2-8.011)
We aimed to characterize the clinical phenotypes of patients with motor neuron disease (MND) in the context of high titer serum/CSF GAD65 antibodies (radioimmunoassay).
Authors
- Naveen Kumar Paramasivan (ORCID: https://orcid.org/0000-0002-2185-4385)
- Αναστασία Ζεκερίδου (ORCID: https://orcid.org/0000-0002-1960-9065)
- Christopher W. Klein
- Pallab Sarker (ORCID: https://orcid.org/0000-0003-2388-4155)
- Divyanshu Dubey (ORCID: https://orcid.org/0000-0001-6865-9045)
- Andrew B. McKeon (ORCID: https://orcid.org/0000-0001-6856-8143)
- Nathan P. Staff (ORCID: https://orcid.org/0000-0001-6760-3859)
- Sean Joseph Pittock (ORCID: https://orcid.org/0000-0002-6140-5584)
Institutions
- WinnMed (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212221
- Primary Topic
- Pharmacological Receptor Mechanisms and Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00